Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2513-2516

  Brunner, Georg ^a,d   Zalkow, Leon ^b   Burgess, Edward ^b   Rifkin, Daniel B ^a   Wilson, E Lynette ^a   Gruszecka Kowalik, Ewa ^b   Powis, Garth ^c  

^a Kaplan Cancer Center   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Glycosylphosphatidylinositol phospholipase D; Suramin analogues

Indexed keywords

AZO COMPOUND; DRUG DERIVATIVE; GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SURAMIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELL DIVISION; HT29 CELLS; HUMANS; PHOSPHOLIPASE D; SURAMIN; TUMOR CELLS, CULTURED;

EID: 0029909349     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Takeda J and Kinoshita T: GPI-anchor biosynthesis. Trends Biochem Sci 20: 367-371, 1995.
2. Ferguson MA: Colworth Medal Lecture. Glycosylphosphatidylinositol membrane anchors: The tale of a tail. Biochem Soc Trans 20: 243-256, 1992.
3. Brown D: The tyrosine kinase connection: how GPI-anchored proteins activate T cells. Curr Opin Immunol 5: 349-354, 1993.
4. Mayor S, Rothberg KG and Maxfield FR: Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 264: 1948-1951, 1994.
5. Walter EI, Roberts WL, Rosenberry TL, Ratnoff WD and Medof ME: Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. J Immunol 144: 1030-1036, 1990.
6. Davitz MA, Low MG and Nussenzweig V: Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC) - Selective modification of a complement regulatory protein. J Exp Med 163: 1150-1161, 1986.
7. Duszenko M, Ivanov IE, Ferguson MAJ, Plesken H and Cross GAM: Intracellular transport of a variant surface glycoprotein in Trypanosoma brucei. J Cell Biol 106: 77-86, 1988.
8. Deeg MA and Davitz MA: Glycosylphosphatidylinositol-phospholipase D: a tool for glycosylphosphatiidylinositol structural analysis. Methods Enzymol 250: 630-640, 1995.
9. Metz CN, Brunner G, Choi-Muira NH, Nguyen H, Gabrilove J, Caras IW, Altszuer N, Rifkin DB, Wilson EL and Davitz MA: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13: 1741-1751, 1994.
10. Tsang TC, Fung W-J, Levine J, Metz CN, Davitz MA, Burns DK and Huang D-S: Isolation and expression of two human glycosylphosphatidylinositol phospholipase D (GPI-PLD) cDNAs. FASEB J 6: A1922, 1992.
11. Maguire GA and Gossner A: Glycosyl phosphatidyl inositol phospholipase D activity in human serum. Ann Clin Biochem 32 (Pt 1): 74-78, 1995.
12. Furley AJ, Morton SB, Manalo D, Karagogeos D, Dodd J and Jessell TM: The axonal glycoprotein TAG-1 is an immunoglobulin supe Ramily member with neurite outgrowth-promoting activity. Cell 61: 157-170, 1990.
13. Brunner G, Metz CN, Nguyen H, Gabrilove J, Patel SR, Davitz MA, Rifkin DB and Wilson EL: An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood 83: 2115-2125, 1994.
14. Kozikowski AP, Powis G, Fauq AH, Tuckmantel W and Gallegos A: Synthesis and biological activity of the D-3-deoxy-3-fluoro and D-3-deoxy analogues of phosphatidylinositol. J Org Chem 59: 963-971, 1994.
15. Hill SR, Bonjouklian R, Powis G, Abraham RT, Ashendel CL and Zalkow LH: A multisample assay for inhibitors of phosphatidylinositol phospholipase C: Identification of naturally occurring peptide inhibitors with antiproliferative activity. Anti-Cancer Drug Design 9: 353-361, 1994.
16. Powis G, Lee-See K, Santonc KS, Melder DC and Hodnett EM: Quinoneimines as substrates for quinone reductase (NAD(P)H:(quinone-acceptor) oxidoreductase) and the effect of dicumarol on their cytotoxicity. Biochem Pharmacol 36: 2473-2479, 1987.
17. 2+ signalling and cell growth by polysulfated azo dyes related to the antitumor agent suramin. Cancer Chemother Pharmacol 31: 223-228, 1992.
18. Powis G, Seewald MJ, Aksoy I, Riebow J and Melder D: Inhibition of phosphatidylinositol specific phospholipase C (PIPLC) by ether lipid analogues. Proc Am Assoc Cancer Res 32: 399, 1991.
19. Muller-Decker K: Interruption of TPA-induced signais by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem Biophys Res Commun 162: 198-205, 1989.
20. Low MG and Huang KS: Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Biochem J 279 (Pt 2): 483-493, 1991.
21. Low MG and Prasad AR: A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci USA 85: 980-984, 1988.
22. Bergman AS and Carlsson SR: Saponin-induced release of cell-surface-anchored Thy-1 by serum glycosylphosphatidylinositol-specific phospholipase D. Biochem J 298 (Pt 3): 661-668, 1994.
23. Xie M and Low MG: Expression and secretion of glycosylphosphatidylinositol-specific phospholipase D by myeloid cell lines. Biochem J 297 (Pt 3): 547-554, 1994.
24. Xie M, Sesko AM and Low MG: Glycosylphosphatidylinositol-specific phospholipase D is localized in keratinocytes. Am J Physiol 265 (4, Pt 1): C1156-C1168, 1993.
25. Low MG and Huang KS: Phosphatidic acid, λysophosphatidic acid, and lipid A are inhibitors of glycosylphosphatidylinositol-specific phospholipase D. Specific inhibition of a phospholipase by product analogues? J Biol Chem 268: 8480-8490, 1993.
26. Low MG: Molecular and Cell Biology of Membrane Proteins: Glycolipid Anchors of Cell Surface Proteins Chichester, Ellis Horwood, Ltd., 1990, pp 35-63.